EUVIMEDEUVIMED entdecken
Open Access

Efficacy and Safety of Direct‐Acting Oral Anticoagulants in Atrial Fibrillation With Hypertrophic Cardiomyopathy

Amro Taha, Avilash Mondal iD, Usman Ali Akbar iD, Aobo Li iD, Harigopal Sandhyavenu iD, Mohamed Alhajji, Sittinun Thangjui iD, Harshith Thyagaturu iD, Christopher Bianco iD, Marco Caccamo iD, Ahmad Masri iD, Sudarshan Balla iD

Journal of the American Heart Association · 2026

DOI: 10.1161/jaha.125.045998 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Amro Taha und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology West Virginia University Morgantown WV USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Cardiomyopathy, Hypertrophic, Factor Xa Inhibitors, Thromboembolism. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with hypertrophic cardiomyopathy (HCM) were excluded from pivotal trials comparing the efficacy and safety of direct oral anticoagulants (DOACs) and vitamin K antagonists.

Methods

Our retrospective cohort study using the TriNetX database compared adults with HCM‐atrial fibrillation who initiated DOACs or vitamin K antagonists. The primary outcomes were all‐cause mortality and ischemic stroke/systemic thromboembolism. Secondary outcomes included major bleeding, intracranial hemorrhage, gastrointestinal bleeding, and all‐cause hospitalization. Subgroup analysis was conducted for obstructive HCM.

Results

Among 13 143 patients with HCM‐atrial fibrillation (2963 matched pairs). DOAC use was associated with lower all‐cause mortality (hazard ratio [HR], 0.82[ 95% CI, 0.73–0.93]; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCardiomyopathy, HypertrophicFactor Xa InhibitorsThromboembolismAnticoagulantsIschemic StrokeHumansFemaleMaleRetrospective StudiesAgedAdministration, OralMiddle AgedTreatment OutcomeVitamin KHemorrhageRisk FactorsGastrointestinal HemorrhageAged, 80 and over

Stichwörter der Autor:innen

direct oral anticoagulantshypertrophic cardiomyopathynonvalvular atrial fibrillationstrokevitamin K antagonists

Substanzen

Factor Xa InhibitorsVitamin KAnticoagulants

Autor:innen und Institutionen

  • Department of Cardiology West Virginia University Morgantown WV USA.
  • Department of Internal Medicine WVU Camden Clark Medical Center Parkersburg WV USA.
  • Department of Internal Medicine Inspira Medical Center Vineland New Jersey USA.
  • Department of Cardiovascular Medicine University of Texas San Antonio Texas USA.
  • Division of Cardiovascular Medicine Oregon Health and Science University School of Medicine Portland Oregon USA.

ORCID-Profile: Avilash Mondal, Usman Ali Akbar, Aobo Li, Harigopal Sandhyavenu, Sittinun Thangjui, Harshith Thyagaturu, Christopher Bianco, Marco Caccamo, Ahmad Masri, Sudarshan Balla

Zitieren

APA

Taha, A., Mondal, A., Akbar, U. A., Li, A., Sandhyavenu, H., Alhajji, M., Thangjui, S., Thyagaturu, H., Bianco, C., Caccamo, M., Masri, A., & Balla, S. (2026). Efficacy and Safety of Direct‐Acting Oral Anticoagulants in Atrial Fibrillation With Hypertrophic Cardiomyopathy. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.045998

Vancouver

Taha A, Mondal A, Akbar UA, Li A, Sandhyavenu H, Alhajji M, et al. Efficacy and Safety of Direct‐Acting Oral Anticoagulants in Atrial Fibrillation With Hypertrophic Cardiomyopathy. Journal of the American Heart Association. 2026. doi:10.1161/jaha.125.045998

BibTeX
@article{Taha2026,
  author = {Taha, Amro and Mondal, Avilash and Akbar, Usman Ali and Li, Aobo and Sandhyavenu, Harigopal and Alhajji, Mohamed and Thangjui, Sittinun and Thyagaturu, Harshith and Bianco, Christopher and Caccamo, Marco and Masri, Ahmad and Balla, Sudarshan},
  title = {Efficacy and Safety of Direct‐Acting Oral Anticoagulants in Atrial Fibrillation With Hypertrophic Cardiomyopathy},
  journal = {Journal of the American Heart Association},
  year = {2026},
  doi = {10.1161/jaha.125.045998}
}
Kostenlos starten →